...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Peptidyl Aldehyde NK-1.8k Suppresses Enterovirus 71 and Enterovirus 68 Infection by Targeting Protease 3C
【24h】

Peptidyl Aldehyde NK-1.8k Suppresses Enterovirus 71 and Enterovirus 68 Infection by Targeting Protease 3C

机译:肽醛NK-1.8k通过靶向蛋白酶3C抑制肠病毒71和肠病毒68感染

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Enterovirus (EV) is one of the major causative agents of hand, foot, and mouth disease in the Pacific-Asia region. In particular, EV71 causes severe central nervous system infections, and the fatality rates from EV71 infection are high. Moreover, an outbreak of respiratory illnesses caused by an emerging EV, EV68, recently occurred among over 1,000 young children in the United States and was also associated with neurological infections. Although enterovirus has emerged as a considerable global public health threat, no antiviral drug for clinical use is available. In the present work, we screened our compound library for agents targeting viral protease and identified a peptidyl aldehyde, NK-1.8k, that inhibits the proliferation of different EV71 strains and one EV68 strain and that had a 50% effective concentration of 90 nM. Low cytotoxicity (50% cytotoxic concentration, >200 mu M) indicated a high selective index of over 2,000. We further characterized a single amino acid substitution inside protease 3C (3C(pro)), N69S, which conferred EV71 resistance to NK-1.8k, possibly by increasing the flexibility of the substrate binding pocket of 3C(pro). The combination of NK-1.8k and an EV71 RNA-dependent RNA polymerase inhibitor or entry inhibitor exhibited a strong synergistic anti-EV71 effect. Our findings suggest that NK-1.8k could potentially be developed for anti-EV therapy.
机译:肠病毒(EV)是亚太地区手足口病的主要病原体之一。特别地,EV71引起严重的中枢神经系统感染,并且EV71感染的致死率很高。此外,最近在美国1000多名幼儿中爆发了由新出现的EV68引起的呼吸道疾病暴发,并且也与神经系统感染有关。尽管肠道病毒已成为全球公共卫生的重大威胁,但尚无用于临床的抗病毒药物。在当前的工作中,我们筛选了化合物库中靶向病毒蛋白酶的试剂,并鉴定了一种肽醛NK-1.8k,该肽醛可抑制不同EV71菌株和一种EV68菌株的增殖,且50%有效浓度为90 nM。低的细胞毒性(50%的细胞毒性浓度,> 200μM)表明选择性指数超过2,000。我们进一步表征了蛋白酶3C(3C(pro))N69S内部的单个氨基酸取代,这可能通过增加3C(pro)的底物结合口袋的柔韧性赋予EV71对NK-1.8k的抗性。 NK-1.8k和EV71 RNA依赖性RNA聚合酶抑制剂或进入抑制剂的组合表现出很强的协同抗EV71作用。我们的发现表明,NK-1.8k可能被开发用于抗EV治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号